2024
conference-abstract
OpenAlex
Sebastian Fähndrich, Christian Herr, Sebastian Teuteberg, Peter J. Alter et autres
Background: When chronic obstructive pulmonary disease (COPD) is newly diagnosed in the mild to moderate stages (Global Initiative for chronic obstructive Lung Disease [GOLD] stage 0-2), it is difficult to identify patients at increased risk of death. Methods: Therefore, we examined the …
de
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sebastian Fähndrich, Christian Herr, Sebastian Teuteberg, Peter J. Alter et autres
BACKGROUND: MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, less is known about these biomarkers in …
de
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Sebastian Fähndrich, Christian Herr, Sebastian Teuteberg, Peter J. Alter et autres
Abstract Background: A number of prognostic markers of mortality are known in chronic obstructive pulmonary disease (COPD) but less so for early and mild stages of the disease. We thus analyzed several biomarkers as potential predictors of mortality in early COPD. Methods: …
de
(code pays fourni par la source)
2022
conference-abstract
OpenAlex
Sebastian Fähndrich, Sebastian Teuteberg, C Herr, H Watz et autres
Rationale: Chronic obstructive disease (COPD) is one of the most common respiratory diseases caused by exogenous noxae. Multiple comorbidities are characteristic of this chronic systemic disease. The FDA-approved biomarker for predicting disease prognosis competes with other (not approved) biomarkers such as proadrenomedullin …
de
(code pays fourni par la source)